A Northwestern Medicine study has identified a gene set that can predict whether a transplanted kidney is at risk of damage and subsequent loss.
Browsing: Disease Discoveries
Northwestern Medicine scientists have identified a signaling pathway that regulates the behavior of two subtypes of glioblastomas.
A new pathway in the brain can be manipulated to alleviate depression, offering a promising new target for developing a drug that could be effective in individuals for whom other antidepressants have failed.
A 3-D printable ink developed by Northwestern scientists produces synthetic bone implants with unique properties to induce bone regeneration.
Northwestern Medicine scientists continue to demonstrate that a protein called Hrd1 may be an important target for treating autoimmune diseases.
For the last decade, Ronald Ackermann, MD, MPH, has worked on implementing a method to halt diabetes that is both effective for patients and affordable for insurers. He and colleagues have focused on adapting an intervention called the Diabetes Prevention Program.
Northwestern Medicine scientists co-authored a study that identified a blood cell not normally found in the healthy brain that can invade brain tissue after status epilepticus, a type of seizure, and contributes to inflammation.
Analyzing a patient’s own stem cells can predict the safety and efficacy of drugs that have the potential to damage a patient’s heart, according to a new study.
By targeting a hub of schizophrenia-related genes, Northwestern Medicine scientists were able to correct a disease-related alteration in mouse model neurons.
Northwestern Medicine scientists have identified a new potential target for treating autoimmune diseases in recent research published in Nature Communications.